نتایج جستجو برای: programmed cell death 1 ligand 1 protein
تعداد نتایج: 4797326 فیلتر نتایج به سال:
Patients with programmed death-ligand 1 positive (PD-L1+), locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) have a poor prognosis and treatment options are limited. Sitravatinib, selective tyrosine kinase inhibitor, reduces the number of myeloid-derived suppressor cells regulatory T cells, promotes expansion migration antitumor cytotoxic increases ratio M1/M2-pola...
Therapeutic strategies targeting the programmed cell death-ligand 1/programmed cell death-1 pathway have shown significant responses and good tolerability in solid malignancies. Although preclinical studies suggest that inhibiting programmed cell death-ligand 1/programmed cell death-1 interactions might also be highly effective in hematological malignancies, remarkably few clinical trials have ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید